Mapping Atrial Fibrillation in 2020: Key Updates, Emerging Techniques, Unresolved Issues

Description

A whole suite of new approaches to map AF and guide treatment have been developed over the last decade. Many of these remain research tools, whereas others are commercially available. What can guide clinical EPs not involved in the forefront of this field to know which if any, are most suited to augmenting their current clinical practice? Come hear from key proponents in the field and get a state of the art update on how to map AF in 2020.

Presenters

Global Contact Mapping
Sanjiv M. Narayan, MD, PhD, FHRS
Stanford University, Stanford, California

Non-Contact Mapping
Andrew A. Grace, MD, PhD, FHRS
Royal Papworth Hospital NHS Foundation Trust, England, United Kingdom

Body Surface Mapping
Felipe Atienza, MD, FHRS
Hospital General Universitario Gregorio Marañón, Madrid, Spain

Sequential Contact Mapping Using Electrogram Dispersion
Julien Seitz, MD
Hôpital Saint Joseph, Marseille, France

Contact Activation Mapping: Global or Simultaneous?
Atul Verma, MD, FHRS
Southlake Regional Health Centre, Ontario, Canada

Disclosures

S.M. Narayan: Honoraria/Speaking/Consulting Fee - Abbott.

A.A. Grace: Nothing relevant to disclose.

F. Atienza: Honoraria/Speaking/Consulting Fee - Medtronic; MicroPort.

J. Seitz: Salary from Employment (Commercial Interest) - Volta Medical.

A. Verma: Research (Contracted Grants for PIs and Named Investigators only) - Bayer Healthcare Pharmaceuticals; Biotronik. Honoraria/Speaking/Consulting Fee - Biosense Webster, Inc.; Medtronic; Thermedical; VytronUS, Inc.; ACT.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered